Coastline Trust Co Cuts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Coastline Trust Co decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,768 shares of the healthcare conglomerate's stock after selling 1,271 shares during the period. Coastline Trust Co's holdings in UnitedHealth Group were worth $5,116,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Financial Management Professionals Inc. grew its stake in shares of UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after acquiring an additional 17 shares in the last quarter. Richwood Investment Advisors LLC grew its stake in shares of UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after acquiring an additional 20 shares in the last quarter. Global Wealth Strategies & Associates grew its stake in shares of UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after acquiring an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC grew its position in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after buying an additional 21 shares during the period. Finally, Retirement Planning Group LLC grew its position in UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after buying an additional 21 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Robert W. Baird lowered shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target for the company. in a research report on Wednesday, June 11th. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Barclays lowered their price target on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a report on Monday, June 2nd. Wall Street Zen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Raymond James Financial downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus target price of $415.57.

UnitedHealth Group Trading Up 0.4%

NYSE:UNH traded up $1.13 during trading hours on Friday, hitting $308.69. The company had a trading volume of 6,161,145 shares, compared to its average volume of 7,543,771. The company has a market capitalization of $280.03 billion, a PE ratio of 12.93, a price-to-earnings-growth ratio of 1.48 and a beta of 0.45. The stock has a 50-day moving average price of $324.99 and a 200 day moving average price of $447.68. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter last year, the firm earned $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.86%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Kristen Gil purchased 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director owned 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 over the last quarter. Corporate insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.